MEK Inhibition in BRAF-Mutated Melanoma

被引：0
|
作者：
MacKenzie, Alex [1 ]
Boycott, Kym [2 ]
机构：
[1] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada
[2] Univ Ottawa, Ottawa, ON, Canada
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 367卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1364 / 1365
页数：2
相关论文
共 50 条
  • [1] Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
    Flaherty, Keith T.
    Robert, Caroline
    Hersey, Peter
    Nathan, Paul
    Garbe, Claus
    Milhem, Mohammed
    Demidov, Lev V.
    Hassel, Jessica C.
    Rutkowski, Piotr
    Mohr, Peter
    Dummer, Reinhard
    Trefzer, Uwe
    Larkin, James M. G.
    Utikal, Jochen
    Dreno, Brigitte
    Nyakas, Marta
    Middleton, Mark R.
    Becker, Juergen C.
    Casey, Michelle
    Sherman, Laurie J.
    Wu, Frank S.
    Ouellet, Daniele
    Martin, Anne-Marie
    Patel, Kiran
    Schadendorf, Dirk
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02): : 107 - 114
  • [2] Combined BRAF and MEK inhibition for the treatment of BRAF-mutated metastatic melanoma
    Queirolo, Paola
    Picasso, Virginia
    Spagnolo, Francesco
    [J]. CANCER TREATMENT REVIEWS, 2015, 41 (06) : 519 - 526
  • [3] Combination of RAF and MEK Inhibition for the Treatment of BRAF-Mutated Melanoma: Feedback Is Not Encouraged
    Chapman, Paul B.
    Solit, David B.
    Rosen, Neal
    [J]. CANCER CELL, 2014, 26 (05) : 603 - 604
  • [4] Clinical and radiological response of BRAF inhibition and MEK inhibition in patients with brain metastases from BRAF-mutated melanoma
    Foppen, Marnix H. Geukes
    Boogerd, Willem
    Blank, Christian U.
    van Thienen, Johannes V.
    Haanen, John B.
    Brandsma, Dieta
    [J]. MELANOMA RESEARCH, 2018, 28 (02) : 126 - 133
  • [5] Vemurafenib treatment in patients with BRAF-mutated melanoma failing MEK inhibition with trametinib.
    Gogas, Helen
    Schadendorf, Dirk
    Dummer, Reinhard
    Garbe, Claus
    Lebbe, Celeste
    Nathan, Paul D.
    Larkin, James M. G.
    Haydon, Andrew Mark
    Bafaloukos, Dimitris
    Robert, Caroline
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma
    Liu, Xiao
    Wu, Jinfeng
    Qin, Haihong
    Xu, Jinhua
    [J]. TARGETED ONCOLOGY, 2018, 13 (04) : 437 - 446
  • [7] Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
    Spagnolo, Francesco
    Ghiorzo, Paola
    Queirolo, Paola
    [J]. ONCOTARGET, 2014, 5 (21) : 10206 - 10221
  • [8] The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma
    Xiao Liu
    Jinfeng Wu
    Haihong Qin
    Jinhua Xu
    [J]. Targeted Oncology, 2018, 13 : 437 - 446
  • [9] Neurological benefit of BRAF-inhibition and MEK-inhibition in patients with brain metastases from BRAF-mutated melanoma
    Foppen, M. Geukes
    Boogerd, W.
    Blank, C.
    Haanen, J. B. A. G.
    van Thienen, J. V.
    Brandsma, D.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [10] Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
    Alain P. Algazi
    Megan Othus
    Adil I. Daud
    Roger S. Lo
    Janice M. Mehnert
    Thach-Giao Truong
    Robert Conry
    Kari Kendra
    Gary C. Doolittle
    Joseph I. Clark
    Michael J. Messino
    Dennis F. Moore
    Christopher Lao
    Bryan A. Faller
    Rangaswamy Govindarajan
    Amy Harker-Murray
    Luke Dreisbach
    James Moon
    Kenneth F. Grossmann
    Antoni Ribas
    [J]. Nature Medicine, 2020, 26 : 1564 - 1568
12345